Healthcare Industry News: Abbott
News Release - September 4, 2012
Integra LifeSciences Announces Two Key Executive AppointmentsAppoints John Mooradian as Senior Vice President, Global Operations and Supply Chain, and Joseph Vinhais as Senior Vice President, Global Quality Assurance
PLAINSBORO, N.J., Sept. 4, 2012 -- (Healthcare Sales & Marketing Network) -- Integra LifeSciences Holdings Corporation (IART) announced today that John Mooradian and Joseph Vinhais have joined Integra as Senior Vice President, Global Operations and Supply Chain, and Senior Vice President, Global Quality Assurance, respectively, reporting to Peter Arduini, President and CEO.
"I am delighted to have John and Joseph at Integra," said Mr. Arduini. "John brings a depth of operations experience that will be invaluable as we continue evolving our global manufacturing strategy and maximizing our supply chain effectiveness. Joseph will apply his extensive quality and regulatory experience to drive continuous improvement throughout the organization."
Mr. Mooradian, as Senior Vice President of Global Operations and Supply Chain, will be responsible for Integra's newly integrated global manufacturing and supply chain functions. Prior to joining Integra, Mr. Mooradian spent 24 years at Abbott Laboratories in a series of leadership roles, where he significantly improved critical manufacturing processes and systems, and implemented key compliance enhancements. One of Mr. Mooradian's key roles at Abbot was responsibility for worldwide operations at Abbott Diagnostics Division, a $4 billion business with over 11,000 employees.
Mr. Vinhais, as Senior Vice President of Global Quality Assurance, will be responsible for Integra's global quality systems. Mr. Vinhais has over 20 years of global experience in quality assurance, regulatory affairs, compliance, and operations. He was most recently Head of Quality Assurance, Regulatory Affairs, and Sustainability at Philips Healthcare Imaging Systems, where he was responsible for quality assurance and regulatory affairs for the Computed Tomography and Nuclear Medicine business. During his tenure at Philips, Mr. Vinhais played an integral role in developing quality and regulatory strategies for China, as well as other emerging markets, and realigning the quality and regulatory functions to better support the business. Judi O'Grady, Senior Vice President, Global Regulatory Affairs, will lead the Regulatory Affairs department on a global basis.
"These key executive appointments will greatly enhance our ability to achieve our next phase of growth, as we continue to provide high-quality products to surgeons and their patients worldwide," said Mr. Arduini.
Integra LifeSciences, a world leader in medical devices, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. Integra offers innovative solutions in orthopedics, neurosurgery, spine, reconstructive and general surgery. For more information, please visit www.integralife.com.
This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from predicted or expected results. In addition, the economic, competitive, governmental, technological and other factors identified under the heading "Risk Factors" included in Item IA of Integra's Annual Report on Form 10-K for the year ended December 31, 2011 and information contained in subsequent filings with the Securities and Exchange Commission could affect actual results.
Source: Integra LifeSciences
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.